Detalles de la búsqueda
1.
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Am J Hematol
; 99(4): 606-614, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342997
2.
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Cancer
; 129(6): 934-945, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36545710
3.
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.
J Med Virol
; 95(9): e29067, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675796
4.
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Leukemia
; 37(4): 799-806, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807649
5.
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Blood Cancer J
; 14(1): 32, 2024 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38378617
6.
Maternal Knowledge, Attitudes, and Practices Concerning Interpregnancy Interval.
Kans J Med
; 11(4): 86-90, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30937146
7.
Intraobserver reliability of cranial strain patterns as evaluated by osteopathic physicians: a pilot study.
J Am Osteopath Assoc
; 108(9): 493-502, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18806078
8.
An accurate VO2max nonexercise regression model for 18-65-year-old adults.
Res Q Exerc Sport
; 76(4): 426-32, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16739680
Resultados
1 -
8
de 8
1
Próxima >
>>